| The accuracy of surrogate decision makers: a systematic review DI Shalowitz, E Garrett-Mayer, D Wendler Archives of internal medicine 166 (5), 493-497, 2006 | 1115 | 2006 |
| Disclosing individual results of clinical research: implications of respect for participants DI Shalowitz, FG Miller Jama 294 (6), 737-740, 2005 | 299 | 2005 |
| Communicating the results of clinical research to participants: attitudes, practices, and future directions DI Shalowitz, FG Miller PLoS medicine 5 (5), e91, 2008 | 252 | 2008 |
| T cell activation causes diarrhea by increasing intestinal permeability and inhibiting epithelial Na+/K+-ATPase MW Musch, LL Clarke, D Mamah, LR Gawenis, Z Zhang, W Ellsworth, ... The Journal of clinical investigation 110 (11), 1739-1747, 2002 | 220 | 2002 |
| Implications of disclosing individual results of clinical research EW Clayton, LF Ross Jama 295 (1), 37-38, 2006 | 122 | 2006 |
| Geographic access to gynecologic cancer care in the United States DI Shalowitz, AM Vinograd, RL Giuntoli II Gynecologic oncology 138 (1), 115-120, 2015 | 89 | 2015 |
| The ethics of creating a resource allocation strategy during the COVID-19 pandemic N Laventhal, R Basak, ML Dell, D Diekema, N Elster, G Geis, M Mercurio, ... Pediatrics 146 (1), 2020 | 85 | 2020 |
| Survival implications of time to surgical treatment of endometrial cancers DI Shalowitz, AJ Epstein, L Buckingham, EM Ko, RL Giuntoli II American Journal of Obstetrics and Gynecology 216 (3), 268. e1-268. e18, 2017 | 67 | 2017 |
| Disclosing individual CDKN2A research results to melanoma survivors: interest, impact, and demands on researchers KD Christensen, JS Roberts, DI Shalowitz, JN Everett, SYH Kim, L Raskin, ... Cancer Epidemiology, Biomarkers & Prevention 20 (3), 522-529, 2011 | 52 | 2011 |
| How should treatment decisions be made for incapacitated patients, and why? DI Shalowitz, E Garrett-Mayer, D Wendler PLoS Medicine 4 (3), e35, 2007 | 47 | 2007 |
| Are patients willing to travel for better ovarian cancer care? DI Shalowitz, E Nivasch, RA Burger, MM Schapira Gynecologic oncology 148 (1), 42-48, 2018 | 42 | 2018 |
| The search for clarity in communicating research results to study participants DI Shalowitz, FG Miller Journal of Medical Ethics 34 (9), e17-e17, 2008 | 40 | 2008 |
| Informed consent for research and authorization under the Health Insurance Portability and Accountability Act Privacy Rule: an integrated approach D Shalowitz, D Wendler Annals of internal medicine 144 (9), 685-688, 2006 | 37 | 2006 |
| Non-surgical management of ovarian cancer: prevalence and implications DI Shalowitz, AJ Epstein, EM Ko, RL Giuntoli II Gynecologic oncology 142 (1), 30-37, 2016 | 34 | 2016 |
| Returning individual research results: development of a cancer genetics education and risk communication protocol JS Roberts, DI Shalowitz, KD Christensen, JN Everett, SYH Kim, L Raskin, ... Journal of Empirical Research on Human Research Ethics 5 (3), 17-30, 2010 | 34 | 2010 |
| Survival implications of staging lymphadenectomy for non-endometrioid endometrial cancers S Venigalla, AK Chowdhry, DI Shalowitz Gynecologic oncology 149 (3), 531-538, 2018 | 33 | 2018 |
| Teleoncology for gynecologic cancers DI Shalowitz, AG Smith, MC Bell, RK Gibb Gynecologic Oncology 139 (1), 172-177, 2015 | 30 | 2015 |
| Shared decision-making and the lower literate patient DI Shalowitz, MS Wolf Journal of law, medicine & ethics 32 (4), 759-764, 2004 | 28 | 2004 |
| Telemedicine and gynecologic cancer care DI Shalowitz, CJ Moore Obstetrics and Gynecology Clinics 47 (2), 271-285, 2020 | 22 | 2020 |
| Interactions with industry under the Sunshine Act: an example from gynecologic oncology DI Shalowitz, MA Spillman, MA Morgan American Journal of Obstetrics and Gynecology 214 (6), 703-707, 2016 | 22 | 2016 |
